-
December 3, 2018PREVIEW
Switching the manufacturer of antiepileptic drugs increased the risk of seizure recurrence in patients who were previously seizure-free, according to a retrospective, observational study published...
-
November 20, 2018PREVIEW
An assessment of community pharmacists’ understanding of FDA therapeutic equivalence standards and bioequivalence criteria showed that many pharmacists need additional education on these topics,...
-
July 30, 2018PREVIEW
Use of fingolimod (Gilenya—Novartis) or delayed-release dimethyl fumarate (Tecfidera—Biogen) for patients with relapsing-remitting multiple sclerosis (RRMS) appears to have similar efficacy for...
-
June 19, 2018PREVIEW
In April 2018, the American Academy of Neurology (AAN) published an updated guideline in Neurology on the use of disease-modifying agents for patients with multiple sclerosis (MS). The...
-
June 4, 2018PREVIEW
A prospective analysis of data from a European pregnancy registry of antiepileptic drugs published in Lancet Neurology showed that use of valproate had the highest prevalence of major...
Pages
